Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine

PURPOSE: Biliary tract cancers (BTCs), which include intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (EHC), and gallbladder cancer (GBC), have limited treatment options. We sought to comprehensively examine the clinical and molecular characteristics of BTCs with amplification...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JCO Precis Oncol
Main Authors: Mondaca, Sebastian, Razavi, Pedram, Xu, Chongrui, Offin, Michael, Myers, Mackenzie, Scaltriti, Maurizio, Hechtman, Jaclyn F., Bradley, Mikaela, O’Reilly, Eileen M., Berger, Michael F., Solit, David B., Li, Bob T., Abou-Alfa, Ghassan K.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2019
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446346/
https://ncbi.nlm.nih.gov/pubmed/32923849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00223
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares